Stem cell treatment suppresses multiple sclerosis in the long term Nature.com Patients with aggressive multiple sclerosis (MS) can gain long-term benefit from immunoablation followed by autologous haematopoietic stem cell transplantation (I/AHSCT), according to a new study. The evidence from the largest long-term study of the ... See the original post: Stem cell treatment suppresses multiple sclerosis in the long term - Nature.com … Continue reading →

Multiple Sclerosis Awareness Month Katie Orth, KIDY 9:45 AM. CST March 10, 2017 SAN ANGELO, TX - March is Multiple Sclerosis awareness month. According to the CDC more than 2.3 million people are affected by MS worldwide. One west Texas Neurologist is helping those whom are battling the disease. "Multiple Sclerosis is an inflammatory disorder that affects the nervous system, it usually affects the brain and the spinal cord," said Dr. Wael Richeh. A battle that 6 to 8 percent of Americans will face in their lifetime. "I see 10 to 15 new patients with multiple sclerosis a month," said Richeh. Although incurable, he helps treat this awful disease- "Previously we used to have only the injectable medication, and now we have oral medication," said Richeh. He clues us in on early symptoms to look out for- "It might cause double vision, blurry vision; they might affect the strength or cause weakness, inability to use one arm or one leg, sensory problems, tingling and numbness, also balance and urination," added Richeh. Dr. Richeh is the only certified MS Partner In Care between Amarillo and San Antonio. "If they have symptoms they need to be seen by a neurologist and to … Continue reading →

PHOTO PROVIDED From left are Raj Patel, M.D., president of the medical staff, Lock Haven Hospital; Anne Cross, M.D. and George Sadka, M.D., of Susquehanna Eye Associates, following the presentation. LOCK HAVEN The continuing medical education program for members of the Lock Haven Hospital medical staff this month featured a presentation by Anne H. Cross, M.D. from the Potomac Center for Medical Education. The presentation was entitled Integrating New DMD Therapies into the MS Treatment Landscape. In the presentation, Dr. Cross outlined: r Clinical diagnosis supported by a variety of data including blood work, brain MRI (Magnetic Resonance Imaging) and the study of Cerebrospinal fluid (CSF) r Advances in the early diagnosis of multiple sclerosis and the early initiation of disease modifying drug (DMD) therapies in MS r Some of the barriers to DMD treatment adherence by patients and effective responses to those barriers Multiple Sclerosis is a chronic, typically progressive disease involving damage to the sheaths of nerve cells in the brain and spinal cord. People who contract the disease typically display their first symptoms between the ages of 20 and 40 years old and those symptoms may include; numbness or tingling, impairment of speech and of muscular coordination, … Continue reading →